|
| Press Releases |
|
 |
|
| Wednesday, November 20, 2019 |
|
|
Great Potential in RA Therapeutic Market, Sinomab Announces Latest Progress of its Drug Candidate SM03 Phase III Clinical Trial for the Treatment RA |
| SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, is pleased to announce its latest progress of SM03 phase III clinical trial for the treatment rheumatoid arthritis. more info >> |
|
| Monday, November 11, 2019 |
|
|
中国抗体（3681.HK）：商业化进程未来可期 |
| 2018年港交所设立新规，允许未盈利公司在香港主板上市，由此揭开了内地生物科技公司赴港上市热潮的序幕。 more info >> |
|
|
中國抗體（3681.HK）：商業化進程未來可期 |
| 2018年港交所設立新規，允許未盈利公司在香港主板上市，由此揭開了內地生物科技公司赴港上市熱潮的序幕。 more info >> |
|
| Wednesday, October 30, 2019 |
|
|
中国抗体制药宣布于港交所主板上市计划 |
| 中国抗体制药有限公司（「中国抗体制药」或「公司」连同其附属公司，统称「集团」；股份代号：3681.HK），专门研究、发展、制造及商业化免疫性疾病疗法且主要研制以单克隆抗体为基础的生物药的香港生物制药公司，今天宣布于香港联合交易所有限公司（「联交所」）主板上市计划。 more info >> |
|
|
中國抗體製藥宣佈於港交所主板上市計劃 |
| 中國抗體製藥有限公司（「中國抗體製藥」或「公司」連同其附屬公司，統稱「集團」；股份代號：3681.HK），專門研究、發展、製造及商業化免疫性疾病療法且主要研製以單克隆抗體為基礎的生物藥的香港生物製藥公司，今天宣佈於香港聯合交易所有限公司（「聯交所」）主板上市計劃。 more info >> |
|
|
SinoMab BioScience Announces Proposed Listing on the Main Board of SEHK |
| SinoMab BioScience Limited ("SinoMab BioScience" or the "Company", together with its subsidiaries, the "Group"; stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
AJ Issenman Joins AELF FlightService as Director of Capital Markets
Dec 4, 2023 23:00 HKT/SGT
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 22:52: JST
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 21:49 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 21:26: JST
|
|
|
Wiz Acquires Raftt, Bolsters CNAPP Offering for Cloud and Kubernetes Developers
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生產前已獲得充分資金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生产前已获得充分资金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium Fully Funded to First Production in 2024
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Q2 Metals Receives Proceeds of $2.0 Million from Shareholder Warrant Exercises
Dec 4, 2023 20:39 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 20:20 HKT/SGT
|
|
|
Pertamina Reaffirms its Commitment to Net Zero Emissions by 2060
Dec 4, 2023 20:00 HKT/SGT
|
|
|
DENSO Announces Organizational and Executive Changes
Dec 4, 2023 18:12 JST
|
|
|
All-New Triton Earns Top Rating in 2023 ASEAN NCAP
Dec 4, 2023 17:07 JST
|
|
|
KJTS Group Berhad Inks Underwriting Agreement with Hong Leong Investment Bank
Dec 4, 2023 16:00 HKT/SGT
|
|
|
Novationwire's Media Connections in Indonesia Enable Smooth Press Release Distribution For Users
Dec 4, 2023 11:26: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
